2Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymerbased paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial [ J ]. JAMA, 2005, 294(10) : 1215 - 1223.
3Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions [ J ]. Circulation, 2004, 109 ( 10 ) : 1244 - 1249.
4Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term resuits of drug-eluting stent implantation in unprotected left main[ J]. Circulation, 2005, 111 (6) :791 - 795.
5Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease [ J ]. N Engl J Med, 2004, 350(3) :221 -231.
6Iakovou I, Schmidt T, Ge L, et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation[ J]. J Am Coll Cardiol, 2005, 45(5) :805 -806.
7Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus-or paclitaxel-eluting stents [J]. Circulation, 2006, 113(19) :2293 -2300.
8Lee CW, Park DK, Lee BK, et al. Predictors of restenosis after placement of drug-eluting Stents in one or more coronary arteries [J]. Am J Cardiol, 2006, 97(4) :506 -511.
9Hong MK, Lee CW, Kim YH, et al. Intravascular ultrasound predictors and their cut-off values for angiographic restenosis after sirolimus-eluting stent implantation [ J ]. JACC, 2006, 47 (4) : 189A.
10Mauri L, O' Malley A J, Popma JJ, et al. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents [ J ]. Am J Cardiol, 2005, 95 ( 10 ) : 1140 - 1145.
3Williams DO,Holubkov R,Yeh W,et al.Percutaneous coronary intervention in the eurrent era compared with 1985-1986:the national heart,lung,and blood Institute registries[J].Circulation,2000,102 (24):2945-2951.
4Holmes DR Jr.State of the art in coronary intervention[J].Am J Cardiol,2003,91 (3A):50A -53A.
5Marx SO,Marks AR.Bench to Bedside.The Development of rapamycin and its application to stent restenosis[J].Circulation,2001,104(8):852 -855.
6Shin EK,Son JW,Sohn MS,et al.Efficacy of heparin-coated stent in early setting of acute myocardial infraction[J].Caheter Cardiovasc Interv,2001,52(3):306-312.
7Vrolix MC,Legrand VM,Reiber JH,et al.Heparin-coated Wiktor stents in human coronary arterics(MENTOR trail)[J].Am J Cadio,2000,86(4):385-389.
